Thrainsson Leifur, Halldorsson Arnljotur Bjorn, Ingason Arnar Bragi, Isaksson Helgi J, Gudmundsson Gunnar, Gudbjartsson Tomas
Division of Cardiothoracic Surgery, Landspitali University Hospital, Reykjavik, Iceland.
Division of Radiology and Imaging Studies, Landspitali University Hospital, Reykjavik, Iceland.
J Thorac Dis. 2024 Jan 30;16(1):99-112. doi: 10.21037/jtd-23-1107. Epub 2024 Jan 11.
Surgical lung biopsy (SLB) is required for diagnosis in patients with suspected interstitial lung disease (ILD) if other less invasive diagnostic methods are non-conclusive. We evaluated the outcome of SLB by using centralized databases in a whole-nation patient-cohort.
A population-based retrospective study on 68 consecutive patients (mean age 58 years, 58.8% males) that underwent SLB in Iceland between the years 2008 and 2020. Patient information was obtained from patient charts and peri- and postoperative complications were registered together with 30- and 90-day mortality. Computed tomography (CT) scans, histological biopsies and spirometry results were reviewed, and overall survival (Kaplan-Meier) estimated. Mean follow-up was 61.3 months (range, 3-155 months).
Out of 68 SLB-patients 41 (60.3%) had preoperatively undergone non-conclusive transbronchial biopsies (TBB) obtained with bronchoscopy. Spirometry showed forced vital capacity (FVC) 3.0 L and forced expiratory volume in 1 second (FEV1) 2.3 L, or 73.0% and 71.6% of predicted value, respectively. Video-assisted thoracoscopic surgery (VATS) technique was used in all cases and provided a histologic and disease specific diagnosis in 92.6% of cases; most often being nonspecific interstitial pneumonia (NSIP) (29.4%) and usual interstitial pneumonia (UIP) (23.5%). One patient (1.5%) sustained a major postoperative complication (excessive bleeding) and seven patients (10.3%) minor complications. Median chest tube time and length of stay was 1 and 2 days, respectively. No patients died <90 days postoperatively. Overall survival at 1 and 5 years was 95.6% and 73.5%, respectively, and 5-year survival for NSIP and UIP was 85% and 43.7%, respectively. Long-term mortality for UIP was four times higher when compared with NSIP and other diagnosis.
Lung biopsy with VATS-technique provided a definitive histological and disease specific diagnosis in majority of cases. The procedure is safe, reflected in low complication-rates and short hospital stay, and can therefore be used to diagnose and tailor treatment of ILD patients.
对于疑似间质性肺疾病(ILD)的患者,如果其他侵入性较小的诊断方法无法得出结论,则需要进行外科肺活检(SLB)以明确诊断。我们通过全国患者队列的集中数据库评估了SLB的结果。
对2008年至2020年间在冰岛接受SLB的68例连续患者(平均年龄58岁,男性占58.8%)进行基于人群的回顾性研究。从患者病历中获取患者信息,并记录围手术期和术后并发症以及30天和90天死亡率。回顾计算机断层扫描(CT)扫描、组织活检和肺功能测定结果,并估计总生存期(Kaplan-Meier法)。平均随访时间为61.3个月(范围3 - 155个月)。
68例SLB患者中,41例(60.3%)术前接受了通过支气管镜获得的非诊断性经支气管活检(TBB)。肺功能测定显示用力肺活量(FVC)为3.0L,第1秒用力呼气量(FEV1)为2.3L,分别为预测值的73.0%和71.6%。所有病例均采用电视辅助胸腔镜手术(VATS)技术,92.6%的病例获得了组织学和疾病特异性诊断;最常见的是非特异性间质性肺炎(NSIP)(29.4%)和寻常型间质性肺炎(UIP)(23.5%)。1例患者(1.5%)发生了严重术后并发症(大出血),7例患者(10.3%)发生了轻微并发症。胸腔引流管留置时间中位数和住院时间分别为1天和2天。术后90天内无患者死亡。1年和5年总生存率分别为95.6%和73.5%,NSIP和UIP的5年生存率分别为85%和43.7%。与NSIP和其他诊断相比,UIP的长期死亡率高出四倍。
VATS技术进行的肺活检在大多数病例中提供了明确的组织学和疾病特异性诊断。该手术安全,并发症发生率低且住院时间短,因此可用于ILD患者的诊断和治疗方案制定。